Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
NOV Inc is an oil & gas equipment & services business based in the US. NOV shares (NOV) are listed on the NYSE and all prices are listed in US Dollars. NOV employs 27,631 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$12.90|
|52-week range||$7.70 - $18.02|
|50-day moving average||$13.20|
|200-day moving average||$14.74|
|Wall St. target price||$17.57|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.42|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-3.66%|
|1 month (2021-08-24)||-1.75%|
|3 months (2021-06-24)||-16.02%|
|6 months (2021-03-24)||-5.01%|
|1 year (2020-09-24)||27.09%|
|2 years (2019-09-24)||-40.17%|
|3 years (2018-09-24)||43.5|
|5 years (2016-09-23)||33.89|
Valuing NOV stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NOV's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NOV's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $224 million.
The EBITDA is a measure of a NOV's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.4 billion|
|Gross profit TTM||$434 million|
|Return on assets TTM||-2.81%|
|Return on equity TTM||-10.05%|
|Market capitalisation||$5.3 billion|
TTM: trailing 12 months
There are currently 12.4 million NOV shares held short by investors – that's known as NOV's "short interest". This figure is 0.4% down from 12.5 million last month.
There are a few different ways that this level of interest in shorting NOV shares can be evaluated.
NOV's "short interest ratio" (SIR) is the quantity of NOV shares currently shorted divided by the average quantity of NOV shares traded daily (recently around 4.0 million). NOV's SIR currently stands at 3.14. In other words for every 100,000 NOV shares traded daily on the market, roughly 3140 shares are currently held short.
However NOV's short interest can also be evaluated against the total number of NOV shares, or, against the total number of tradable NOV shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NOV's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 NOV shares in existence, roughly 30 shares are currently held short) or 0.0344% of the tradable shares (for every 100,000 tradable NOV shares, roughly 34 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NOV.
Find out more about how you can short NOV stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like NOV.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 38.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and NOV's overall score of 38.8 (as at 01/01/2019) is pretty weak – landing it in it in the 80th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like NOV is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 20.61/100
NOV's environmental score of 20.61 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that NOV is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 19.23/100
NOV's social score of 19.23 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that NOV is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.96/100
NOV's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that NOV is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. NOV scored a 1 out of 5 for controversy – the highest score possible, reflecting that NOV has managed to keep its nose clean.
|Total ESG score||38.8|
|Total ESG percentile||79.7|
|Environmental score percentile||8|
|Social score percentile||8|
|Governance score percentile||8|
|Level of controversy||1|
We're not expecting NOV to pay a dividend over the next 12 months.
NOV's shares were split on a 1109:1000 basis on 2 June 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1109 shares. This wouldn't directly have changed the overall worth of your NOV shares – just the quantity. However, indirectly, the new 9.8% lower share price could have impacted the market appetite for NOV shares which in turn could have impacted NOV's share price.
Over the last 12 months, NOV's shares have ranged in value from as little as $7.7 up to $18.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while NOV's is 2.3155. This would suggest that NOV's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for use in oil and gas drilling and production, and industrial and renewable energy sectors worldwide. It operates through three segments: Wellbore Technologies, Completion & Production Solutions, and Rig Technologies. The company offers various equipment and technologies used to perform drilling operations. It also provides solids control and waste management equipment and services; portable power generation products; drill and wired pipes; drilling optimization and automation services; tubular inspection, repair, and coating services; instrumentation, and measuring and monitoring services; downhole and fishing tools; and drill bits. The company offers equipment and technologies for hydraulic fracture stimulation, including pressure pumping trucks, blenders, sanders, hydration and injection units, flowline, and manifolds; well intervention, such as coiled tubing and wireline units, as well as blowout preventers and tools; onshore production comprising fluid processing systems, composite pipes, surface transfer and progressive cavity pumps, and artificial lift systems; fluid processing and floating production systems, and subsea production technologies; and connectors for conductor pipes. It also provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; blowout preventers; drives and generators; rig instrumentation and control systems; mooring, anchor, and deck handling machinery; equipment components for offshore wind construction vessels; and pipelay and construction systems.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.